Explore the challenges and strategies to deal with health sector corruption
Corruption in the health sector is especially critical in developing and transitional economies lacking in public resources. Corruption lowers the quality, equity, volume and effectiveness of health care. It increases the price of medical services, and discourages people to use and pay for them. This has a corrosive impact on a population's level of health.
This U4 Theme offers resources to:
Prof. Taryn Vian , Amy Studenic, and Kimberly Johnson at the Boston University School of Public Health have contributed substantively to this U4 Theme.
New U4 Publication
U4 Issue 2013:3 by J.C. Kohler and N. Ovtcharenko. 26p
Select global initiatives in the area of good governance and medicines have been particularly useful in generating a political and policy dialogue around the issue of pharmaceutical system good governance. The initiatives examined in this paper have been taken by the World Bank, the WHO and the Global Fund, as well as the Medicines Transparency Alliance. The main findings include that these initiatives identify weaknesses in the pharmaceutical system and can provide important baseline data. Recommendations include the need for political analysis, monitoring and evaluation, and the streamlining and uniformity of assessment tools across institutions.